ABSTRACT Birds have a remarkable longevity for their body size despite an increased body temperature, higher metabolic rate, and increased blood glucose concentrations compared to most mammals. As the end-product of purine degradation, uric acid (UA) is generated in the xanthine/hypoxanthine reactions catalyzed by xanthine oxidoreductase (XOR). In the first study, Cobb × Cobb broilers (n = 12; 4 weeks old) were separated into 2 treatments (n = 6); control (CON) and allopurinol (AL) 35 mg/kg BW (ALLO). The purpose of this study was to assess mitochondrial function in broiler chickens in response to potential oxidative stress generated from the administration of AL for 1 wk. There was a significant reduction in state 3 respiration (P = 0.01) and state 4 respiration (P = 0.007) in AL-treated birds compared to the controls. The purpose of the second study was to assess the effect of AL on gene expression of inflammatory cytokines interferon-γ (IFN)-γ, IL-1β, IL-6, and IL-12p35, as well as inducible nitric oxide synthase and XOR in liver tissue. Cobb × Cobb broilers were separated into two groups at 4 wk age (n = 10); CON and ALLO. After 1 wk AL treatment, half of the birds in each group (CON 1 and ALLO 1) were euthanized while the remaining birds continued on AL treatment for an additional week (CON 2 and ALLO 2). A significant increase in gene expression of XOR, IFN-γ, IL-1β, and IL-12p35 in ALLO 2 birds as compared to birds in CON 2 was detected. Liver UA content was significantly decreased in both ALLO 1(P = 0.003) and ALLO 2 (P = 0.012) birds when compared to CON 1 and CON 2, respectively. The AL reduced liver UA concentrations and increased expression of inflammatory cytokines. Additional studies are needed to determine if AL causes a direct effect on mitochondria or if mitochondrial dysfunction observed in liver mitochondria was due indirectly through increased oxidative stress or increased inflammation.
as inducible nitric oxide synthase and XOR in liver tissue. Cobb × Cobb broilers were separated into two groups at 4 wk age (n = 10); CON and ALLO. After 1 wk AL treatment, half of the birds in each group (CON 1 and ALLO 1) were euthanized while the remaining birds continued on AL treatment for an additional week (CON 2 and ALLO 2). A significant increase in gene expression of XOR, IFN-γ, IL-1β, and IL-12p35 in ALLO 2 birds as compared to birds in CON 2 was detected. Liver UA content was significantly decreased in both ALLO 1(P = 0.003) and ALLO 2 (P = 0.012) birds when compared to CON 1 and CON 2, respectively. The AL reduced liver UA concentrations and increased expression of inflammatory cytokines. Additional studies are needed to determine if AL causes a direct effect on mitochondria or if mitochondrial dysfunction observed in liver mitochondria was due indirectly through increased oxidative stress or increased inflammation.
INTRODUCTION
Birds have a remarkable longevity for their body size despite an increased body temperature, higher metabolic rate, and increased blood glucose concentration compared with mammals (Holmes and Austad, 1995) . Theoretically, birds should sustain a much higher degree of oxidative damage (Barja, 1998) . Despite comparatively low mitochondrial reactive oxygen species (ROS) production, there is cumulative oxidative damage by ROS as evidenced by the accumulation of pentosidine throughout the bird's lifespan (Monnier et al., 1991; Chaney et al., 2003) . To cope with this production of ROS over time, birds must utilize a more efficient antioxidant defense system.
Oxidative stress can contribute to inflammation by activating select transcription factors including Nuclear Factor-κB, Peroxisome proliferator-activated receptorgamma (PPAR-γ), and Activator Protein 1 (AP-1) which are associated with the pathogenesis of disease processes (Reuter et al., 2010) . In turn, activation of these transcription factors can lead to the expression of genes coding for inflammatory cytokines and chemokines amongst other regulatory molecules. ROS are involved in a broad spectrum of diseases associated with chronic inflammation, neurodegenerative diseases, and some cancer mechanisms (Reuter et al., 2010; Settle and Klandorf, 2014) . Induction of these chemokines and cytokines as well as nitric oxide synthase, the enzyme family responsible for the conversion of L-arginine and NADPH to nitric oxide (i.e., NO) and L-citrulline, have been reported to have a role in oxidative stress induced inflammation (Hussain and Harris, 2007) . Furthermore, inducible nitric oxide synthase (iNOS) can be activated by interferon (IFN)-γ (Guzik et al., 2003) . Inflammation, an increase in oxidative stress, and a decrease in NO production have been linked to pulmonary hypertension syndrome and mitochondrial dysfunction in the liver and heart of broiler chickens (Chapman and Wideman, 2006) . Dysfunction of cardiac, liver and lung mitochondria resulting in an increase in ROS production have been linked with inflammation and can be considered a possible underlying factor in pulmonary hypertension syndrome in broilers Iqbal et al., 2001; Tang et al., 2002) .
Birds, comparable to other species, rely on exogenous and endogenous antioxidant defense systems. UA is a potent antioxidant and it is arguably the dominant antioxidant defense mechanism for birds (Klandorf et al., 2001; Simoyi et al., 2002; Machin et al., 2004; Stinefelt et al., 2005; Seaman et al., 2008) . A study by Ames et al. (1981) concluded that the antioxidant properties of uric acid (UA) were due to its ability to scavenge superoxide radicals. In models of multiple sclerosis, urate is also known to scavenge peroxynitrite radicals (Hooper et al., 2002) . Due to the evolutionary lack of urate oxidase expression, also known as uricase, birds (comparable to reptiles, higher primates, and humans) do not convert UA to allantoin; therefore UA is the end product of purine degradation in birds.
The enzyme xanthine oxidoreductase (XOR) catalyzes the reaction between hypoxanthine and xanthine to form uric acid. This enzyme is present in 2 forms: xanthine dehydrogenase and xanthine oxidase. In birds, xanthine dehydrogenase is the predominant form in the liver, kidney, pancreas, intestine, and other tissues (Harrison, 2002) . Recently, however, xanthine oxidase activity has been measured in chicken liver, kidney, pancreas, and intestine (Carro et al., 2009 ). Subcellular localization studies on XOR have shown that the enzyme can be found in the cytoplasm (Frederiks and Vreeling-Sindelorova, 2002) , cellular membranes (Rouquette et al., 1998) , plasma (Adachi et al., 1993) , cytosol (Ichikawa et al., 1992) , and the peroxisome of rat hepatocytes (Angermuller et al., 1987) . Thus, the subcellular localization of XOR remains controversial and wholly undetermined. It has been previously reported that allopurinol (AL), an inhibitor of XOR, reduced tissue UA concentrations in the liver of broiler chickens, thereby creating a residual toxic effect in the liver, which potentially leads to an increase in oxidative damage (Settle et al., 2012) . Furthermore, a combination of the purine precursor to uric acid, inosine, when combined with AL failed to maintain either liver or kidney UA concentrations, whereas XOR activity remained unchanged in the kidney but was lowered in the liver of AL-fed birds which suggested a tissue dependent regulation of this enzyme (Settle et al., 2012) . XOR gene expression was also found to be upregulated in broilers fed AL (Settle et al., 2015) . Lee and Fisher (1972) reported that chicks fed AL at a dose of 75 mg/g feed from 1 to 28 d age showed an increase in XOR activity in the liver concomitant with a decrease in UA content. The researchers suggested that these data provided evidence for a feedback mechanism via the purine precursors to restore tissue UA concentrations.
This study was designed to better understand the factors that regulate XOR gene expression and the role of UA as an antioxidant in the liver tissue. We hypothesized that XOR inhibition with AL would decrease uric acid, which would result in an increase in XOR gene expression in response to the reduced UA levels in an attempt to restore normal physiological concentrations of UA. Second, lowered protection by UA in the liver is hypothesized to induce mitochondrial dysfunction and inflammation leading to an increase in oxidative damage due to increasing ROS from the electron transport chain and ultimately a decline in bird health. To our knowledge, this is the first time that mitochondrial function and markers of inflammation will be measured in the liver tissue of broilers under these experimental conditions. Ultimately, the role of UA as an antioxidant defense has an important role concerning the ability of birds to cope with ROS production and thus contributing to longevity, but the exact mechanism by which this occurs remains largely undetermined.
MATERIALS AND METHODS
All study protocols were approved by the West Virginia University Animal Care and Use Committee.
Study 1
The purpose of this study was to determine the preliminary effects of administering AL on mitochondrial respiration and respiratory control ratio, in order to identify sources of oxidative stress in selected tissues. To our knowledge, a link between reduced UA in the tissue and indices of mitochondrial function has not been established in broiler chickens.
Broilers and study procedures. Twenty mixed-sex Cobb 500 (Cobb × Cobb) broilers (1 d age) were donated from a local hatchery (Pilgrim's Pride, Moorefield, WV) and maintained under standard husbandry practices. At 4 wk age, 12 birds were separated into 2 groups: control (CON; no AL) and AL 35 mg/kg BW (ALLO). As noted, the AL birds were administered AL in the feed at a dose of 35 mg/kg BW. Previously, Carro et al. (2009) and Settle et al. (2012) demonstrated that a dose range of 25 to 50 mg/kg BW successfully lowered plasma and tissue UA, so for this study an intermediary dose of 35 mg/kg BW was selected. BW was measured at the beginning and the end of the study. Birds in the AL group were administered AL for 1 wk. At this time, control and AL birds were euthanized by cervical fracture. Heart (left ventricle) and liver tissue were excised, weighed, and immediately placed in ice-cold PBS pH 7.0 for mitochondrial extraction and analysis. Remaining tissue was stored at −80
• C. Relative liver and heart weights were calculated as the ratio of tissue weight to BW multiplied by 100. Heart tissue was used as a control for the measurement of respiration.
Mitochondrial isolation. Mitochondrial and cytosolic fractions were freshly isolated using the mitochondria/cytosolic fractionation kit (BioVision Inc., San Francisco, CA) according the manufacture's protocol. Briefly, tissues were rinsed in PBS, blotted dry, and then weighed. Approximately 1 g tissue was minced and homogenized. Homogenates were centrifuged at centrifuge at 700 × g (3,000 rpm) for 10 min at 4
• C and supernatant was transferred to a 1.5-mL microcentrifuge tube and spun at 10,000 × g (13,000 rpm) for 30 min at 4
• C. The supernatant was collected (cytosolic fraction) and stored at −80 • C until analyzed. The resulting pellet was resuspended (mitochondrial fraction) in 0.5 mL mitochondria suspension buffer (70 mM sucrose, 220 mM mannitol, 2 mM HEPES at pH 7.4, and 1 mM EDTA). Protein was measured using the Coomassie Bradford Protein Assay Kit Bio Rad (Hercules, CA).
Measurement of state 3 and state 4 respiration and respiratory control ratio. State 3 (active) and state 4 (resting) respiration were measured and analyzed for each tissue type using the OX1LP dissolved oxygen package [Qubit Systems (Kingston, Ontario, Canada)] polarography software. A total of 1.5 mL respiration buffer was added to each chamber along with 1 mg/mL bovine serum albumen to calibrate each chamber. A total of 40 μL each individual sample was added to the chamber at 0 min, 15 μL 1:1 ratio of glutamate (5 nM) and malate (5 mM) was added at 3 min to initiate the electron transport chain, and 6 of 250 mM ADP was added at 5 min to the reaction. Oxygen consumption was read for approximately 40 min/sample. Respiration is reported as millimol oxygen consumed per minute per milligram protein. The first slope of the resulting respiration graph corresponds to state 3 respiration while the second slope corresponds to state 4 respiration. Means for each treatment were analyzed and graphed. Respiratory control ratio (RCR) is calculated by the division of state 3 by state 4 slopes.
Measurement of cytosolic uric acid. Cytosolic UA content was measured using a modification of the protocols for plasma UA from Settle et al. (2012) . Briefly, the UA concentration in 40-μL samples of cytosol from liver and heart tissue was measured by using a commercially available colorometric diagnostic kit (Sigma diagnostic kit procedure 685; Sigma Diagnostics, St. Louis, MO). This method employs uricase to generate H 2 O 2 which reacts with 4-aminoantipyrine and tribromo-3 hydroxy benzoic acid in the presence of peroxidise to form a quinoneimine dye. The resulting change in absorbance at 520 nm is proportional to UA concentration in the sample.
Study 2
The purpose of this study is to establish whether a reduction in UA can lead to an increase in inflammation in the liver tissue and whether XOR gene expression is upregulated in a compensatory response to re-establish antioxidant defense mechanisms. To our knowledge this has not been established for broiler chickens.
Birds and study procedures. Thirty mixed-sex Cobb 500 (Cobb × Cobb) broilers (1 d age) were generously donated from a local hatchery (Pilgrim's Pride, Moorefield, WV) and maintained under standard husbandry practices. At 4 wk age, 20 birds were separated and placed into 2 groups (n = 10/group): CON and ALLO. CON birds were given a commercial diet with no AL inclusion. ALLO birds were administered AL at a dose of 35 mg/kg BW as in study 1. After wk AL administration half of the birds in each group (CON 1 and ALLO 1) were euthanized by cervical fracture. The liver of each bird was removed, placed in a sterile bag, and immediately frozen in liquid nitrogen. Samples were stored in a freezer (−80
• C) until analysis. Remaining birds (CON 2 and ALLO 2) were maintained on treatment for an additional week before euthanasia and tissue removal. Relative liver weight was calculated as described for study 1. Birds in each group were weighed at 0, 3, 6, and 7 d. Additionally, CON 2 and ALLO 2 birds were weighed at 10 and 14 d. Feed intake was monitored at these time intervals as well and doses of AL were adjusted accordingly throughout the study period.
cDNA synthesis. Total mRNA from 1mg of liver tissue was extracted using RNA-Bee isolation medium (Tel-Test, TX) and quantified using a Genequant spectrophotometer. First strand cDNA was synthesized by using Life Technologies' Superscript II Indirect cDNA Labeling System (Life, Carlsbad, CA) according to the manufacturer's instructions. Briefly, each reaction mixture contained 2.5 μL 2.5 mM dNTP mixture, 5.0 μL 5× reverse transcriptase buffer, 2.0 μL 0.1 M dithiothreitol, 0.5 μL RNasin Promega (Madison, WI), and 2.0 μL random hexamer primers [Roche Scientific (Indianapolis, IN) ]. The final cDNA concentration was 1.8 μg/μL. Each sample was heated to 70
• C for 5 min and then 4
• C for 5 min in an MJ Research PTC-200 DNA Engine (MJ Research Inc. Watertown, MA). At this time reverse transcriptase was added to each sample and cycled at 37
• C for 60 min, 90
• C for 5 min, and 4
• C for 5 min. Samples were stored at −80 • C until assayed with real-time reverse transcriptase-PCR (RT-PCR).
Real-time RT-PCR. Primers XOR, IL-1β, IFN-γ, IL-6, IL-12p35, iNOS, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were designed (Table 3) using Primer3 software (Howard Hughes Institute). Each sample was run in triplicate for the XOR and GAPDH primers on a 96-well plate. GAPDH was selected as a housekeeping gene as no differences in expression patterns were expected due to treatment. A pooled sample, that contains cDNA samples from all treatments, was used for both analyses of primer efficiencies. Primers were diluted to 5 μM/μL concentration in nuclease-free water. A serial dilution was used to obtain a standard curve for each primer and the efficiency of each primer was calculated. Primer efficiencies were determined from the slope of the regression line of the log of the cDNA concentrations versus the Ct value by the equation E = 10 (-1/Slope) (Pfaffl, 2001) . The efficiencies were used to calculate the relative mRNA abundance using the "efficiency corrected relative expression" equation (Equation 3; Pfaffl, 2001) . Real time RT-PCR was performed using IQ Sybr Green Supermix (Bio Rad) on a Bio Rad CFX 96 Real-Time System (Bio Rad). Each PCR reaction mixture contained 10 μL IQ Sybr Green Supermix, 3 μL diluted cDNA, 1 μL each of the forward and reverse primer (diluted to 5 μg/μL), and 5 μL nuclease-free water. Each sample was run in triplicate on a 96-well plate. The PCR reaction cycle was as follows: 95
• C for 3 min, 95
• C for 15 s, 60
• C for 30 s, 70
• C for 30 s (repeated for 40 cycles), and then intervals of 95 and 60
• C for 5 min. Liver UA content. Concentration of UA in liver samples was measured using the technique described for cytosolic UA as modified by Settle et al. (2012) . Briefly, 0.5 g liver tissue was weighed and homogenized in 2 mL ice-cold 0.1 M Tris buffer (pH = 7.8) and centrifuged at 14,000 × g at 4
• C for 30 min. Concentrations of UA were analyzed in 40 μL aliquots of the supernatant fraction.
Statistical Analysis. In study 1, the mitochondrial respiration states were analyzed using the t-test function of the GraphPad Prism 6 Software (GraphPad Software Inc., San Diego, CA). Data was analyzed as the difference between groups for state 3 respiration and the difference between groups for state 4 respiration. State 3 was not compared to state 4. BW data, relative liver weight, relative heart weight, RCR, and cytosolic UA content were analyzed by using the t-test function of JMP Software (SAS Institute, Cary, NC).
In study 2, the BW were analyzed as a repeated measures for time by treatment effects from 0 to 7 d for n = 10 birds using the MIXED PROC procedure of SAS (SAS Institute, Cary, NC) to obtain the leastsquared means. Tukey's Honest Significant Difference test was used to determine differences between each group. BW were also analyzed for CON 2 and ALLO 2 birds from 10 to 14 d as using the t-test function and the Wilcoxon/Kruskal-Wallis test of JMP Statistical Software (SAS Institute, Cary, NC) to determine differences between means. Liver UA content was analyzed using the t-test function of JMP Software (SAS Institute, Cary, NC). For both studies, significance was defined as P ≤ 0.05. Statistical significance for gene expression was assessed for each treatment using the t-test procedure of the JMP software (SAS Institute, Cary, NC). Significance was defined as P ≤ 0.05 as compared to the control group of each week.
RESULTS

Study 1
There was no difference in the initial or final BW of the AL bird when compared to birds in the CON group (Table 1) . Relative liver weight of the AL group did not differ significantly from the CON group (Table 1) . Similarly, there was no difference between AL birds and CON birds in terms of relative heart weight ( Table 1) .
Cytosolic UA concentrations measured in heart tissue were significantly increased (P = 0.004) in AL birds as compared to the control (Table 2) . However, no differences were detected in liver cytosolic UA concentrations of AL birds when compared to the control group (Table 2) .
Mitochondrial respiration was measured for heart and liver tissue. There were no significant differences between treatment groups in state 3 or state 4 in the heart as shown in Figure 1A . There was a significant Table 1 . Study 1. Effects of study treatments (CON: 0; AL: 35 mg/kg BW), BW, relative liver weight, and relative heart weight in broilers (n = 6). (P = 0.015) decrease in state 3 respiration in mitochondria isolated from the liver tissue of treated (AL) birds as compared to control ( Figure 1B) . There was also a significant decrease (P = 0.007) in state 4 respiration of Treated (AL) birds as compared to the control ( Figure  2 ). RCR was also significantly decreased (P = 0.035) in liver mitochondria of AL birds when compared to the controls (Table 2) . This difference was not measured in heart tissue of AL birds as compared to the control group.
Study 2
BW (Figure 2 ) did not differ between CON (n = 10) or ALLO (n = 10) birds at d 0, 3, 6, or 7. There was a significant decrease in BW of ALLO 2 birds at d 10 (P = 0.011) and d 14 (P = 0.012) of treatment (Table 4) . Feed intake, measured by weighing back feeders in each pen, did not differ during the 0 to 7 d period between ALLO 1 birds and CON 1 (193 and 195 g/bird/d, respectively). By d 10 and 14 birds in the ALLO 2 group had a reduced feed intake as compared to birds in CON 2 (215 and 230 g/d/bird, respectively).
Liver UA content was reduced (P = 0.002) in ALLO 1 birds as compared to CON 1 after 1 wk Gene expression is represented as the mean ± SEM for each treatment. An asterisk denotes a significant difference as compared to CON 1. Significance is defined as P ≤ 0.05. B. IFN-γ gene expression in broiler liver tissue. ALLO 2 birds (n = 5) were administered 35 mg/kg BW allopurinol in feed for 2 wk. CON 2 (n = 5) were maintained on a commercial diet. Gene expression is represented as the mean ± SEM for each treatment. An asterisk denotes a significant difference as compared to CON 1. Significance is defined as P ≤ 0.05. treatment (Table 5) . Liver UA was also decreased (P = 0.011) in ALLO 2 when compared to CON 2 birds (Table 5) . Relative liver weight did not differ between CON 1 and ALLO 1 groups after 1 wk or between CON 2 and ALLO 2 groups after 2 wk (Table 5) .
After 1 wk treatment, there were no differences between CON 1 and ALLO 1 birds in IFN-γ gene expression in liver tissue (Figure 2A ). However, there was a numerical increase (P = 0.071) in IL-1β gene expression in the liver of ALLO 1 birds when compared to CON 1 ( Figure 3A ). No differences in liver gene expression of IL-12p35 were observed in ALLO 1 birds as compared to CON 1 ( Figure 5A ). Similarly, there were no differences in iNOS between the groups ( Figure 6A ). No significant changes in IL-6 expression in the liver of ALLO 1 birds were measured after 1 wk treatment ( Figure 4A ). There was no change in expression of XOR in ALLO 1 birds as compared to CON 1 ( Figure 7A ).
After 2 wk treatment, however, there was a significant increase (P = 0.0355) in gene expression of IFN-γ in the liver tissue of ALLO 2 birds as compared to the control group ( Figure 2B ). There was also a Table 3 . Primer sets. Primers were designed using the Primer3 Software (Howard Hughes Institute). Primer efficiency was tested prior to use in the experiment. Primers are arranged 5 to 3 with forward and reverse sequences for each gene used in Study 2. Primer  Forward 5 to 3  Reverse 5 to 3   XOR  CTGCAGGATGCCTGCCGCTT  GCATGGGCTTGGGTGCTGGT  IFN-gamma  GTGGTGAGCTTCTGGCAGAG  GCTTGCAGGCTGACGGTAA  IL1-B  GCATCAAGGGCTACAAGCTC  CAGGCGGTAGAAGATGAAGC  IL-6  CTCCTCGCCAATCTGAAGTC  CCCTCACGGTCTTCTCCATA  IL-12p35  GCCCCGTACTGGAAAGTTCT  GGATGTCAGCACCCTCAGAT  iNOS  CCTTTCAACGGCTGGTACAT  CCAGTCCCATTCTTCTTCCA  GAPDH GACGTGCAGGAACACTA CTTGGACTTTGCCAGAGAGG Table 4 . Study 2. Effects of study treatments on BW in CON and ALLO broilers (n = 10) for d 0 to 7 and CON 2 and ALLO 2 broilers (n = 5) on d 10 and 14. significant increase in expression of IL-1β (P = 0.013), and IL-12p35 (P = 0.028) in ALLO 2 birds as compared to CON 2 birds ( Figures 3B and 5B respectively) . However, there was no change in IL-6 expression in the liver tissue between CON 2 and ALLO 2 birds ( Figure  4B ). There was a numerical trend (P = 0.076) in the expression of iNOS in ALLO 2 birds when compared to CON 2 ( Figure 6B ). XOR gene expression was increased (P = 0.051) in the liver tissue of ALLO 2 birds as compared to the CON 2 group ( Figure 7B ).
DISCUSSION
Study 1
In agreement with previous studies Settle et al., 2012) , there was no adverse effect after 1 wk AL treatment on BW as compared to control. These results also confirm a study in which chicks were administered AL (750 mg/kg feed) from hatch to 28 d and noted no adverse effects on BW . Relative liver weight was not different between CON and AL groups, consistent with Carro et al. (2009) .
Of note, mitochondrial state 3 and state 4 respiration was significantly reduced in the liver of AL birds. Broilers with pulmonary hypertension syndrome have been shown to have a decrease in state 3 and state 4 respiration in heart, liver, and breast tissue, indicative of reduced mitochondrial function Tang et al., 2002) . As anticipated, heart mitochondria did not exhibit differences between treatments in state 3 or state 4. Heart tissue acted as a control for the assay as it is not a known target tissue of AL (Pacher et al., 2006) . RCR, another indicator of mitochondrial function in tissues, measures the coupling of the electron transport chain (Estabrook, 1967) . RCR in the liver was significantly reduced in the liver of AL birds (Table 2) which further indicates that AL negatively impacts mitochondrial function in young broilers. However, there was no difference in RCR of the heart, which indicates that there was no effect of treatment on mitochondrial function of the heart. Settle et al. (2012) found that there was a residual toxic effect of AL-fed birds in the liver tissue even after removal of AL from the diet for 1 wk which contributes to an increase in oxidative damage. Mitochondrial complexes I and III are the primary sources of endogenous ROS and proton leak is greater during disease pathogenesis (Chen et al., 2003) . The results suggest that the mitochondrial dysfunction in the liver tissue of AL-fed birds is increased and that this is a contributing factor to oxidative damage in this tissue. ALLO 1 birds (n = 5) were administered 35 mg/kg BW allopurinol in feed for 1 wk. CON 1 (n = 5) were maintained on a commercial diet. Gene expression is represented as the mean ± SEM for each treatment. An asterisk denotes a significant difference as compared to CON 1. Significance is defined as P ≤ 0.05. B. IL-1β gene expression in broiler liver tissue. ALLO 2 birds (n = 5) were administered 35 mg/kg BW allopurinol in feed for 2 wk. CON 2 (n = 5) were maintained on a commercial diet. Gene expression is represented as the mean ± SEM for each treatment. An asterisk denotes a significant difference as compared to CON 1. Significance is defined as P ≤ 0.05. AL at doses of 10 to 50 mg/kg BW inhibits the enzyme XOR thereby inhibiting UA production, which reduces plasma and tissue UA concentrations in broiler chickens (Klandorf et al., 2001; Simoyi et al., 2002; Carro et al., 2009; Settle et al., 2012) . UA is higher in the cytosol of human cells and concentrations increase when injured cells undergo degradation of their RNA and DNA (Shi et al., 2003) . Interestingly, there was a significant increase in cytosolic UA in the heart tissue of AL birds as compared to the control birds. UA is known to be a potent antioxidant for birds (Simoyi et al., 2002; Stinefelt et al., 2005) and ameliorates mitochondrial dysfunction when administered in a combination with anti-TNF (Tumor Necrosis Factor) antibody to ob/ob mice (Garcia-Ruiz et al., 2006) . It is possible that the increase in cytosolic UA results in an enhanced antioxidant protection of the heart tissue, for a reduction in UA results in an increase in oxidative stress (Klandorf et al., 2001 ). Interestingly, there was a tissue-specific response as this effect was evidenced by the increase in UA in the heart but not in the liver. A. IL-6 gene expression in broiler liver tissue. ALLO 1 birds (n = 5) were administered 35 mg/kg BW allopurinol in feed for 1 wk. CON 1 (n = 5) were maintained on a commercial diet. Gene expression is represented as the mean ± SEM for each treatment. An asterisk denotes a significant difference as compared to CON 1. Significance is defined as P ≤ 0.05. B. IL-6 gene expression in broiler liver tissue. ALLO 2 birds (n = 5) were administered 35 mg/kg BW allopurinol in feed for 2 wk. CON 2 (n = 5) were maintained on a commercial diet. Gene expression is represented as the mean ± SEM for each treatment. An asterisk denotes a significant difference as compared to CON 1. Significance is defined as P ≤ 0.05.
Study 2
In the second study, AL (35 mg/kg BW) was administered to broiler chicks over a 2-wk period. During the first week of treatment, there were no differences in BW between control and AL-fed birds, consistent with the results found in study 1. However, by d 10 and 14, there was a significant reduction in BW of ALLO 2 birds compared with CON 2 consistent with previous studies in which a decrease in BW signifies a decline in bird health concomitant with an increase in oxidative stress (Klandorf et al., 2001; Simoyi et al., 2002; Carro et al., 2009; Settle et al., 2012) . Inflammation has been shown to depress growth of broilers by decreasing appetite and enhancing catabolism in the muscle tissue (Klasing, 2007; Niewold, 2010; Khadem et al., 2014) . It is possible that the decrease in BW of ALLO 2 birds can be attributed to inflammation as gene expression of cytokines (IFN-γ, IL-1β, and IL-12p35) was upregulated in the liver tissue.
Liver UA concentrations were markedly reduced in ALLO 1 and ALLO 2 birds as compared with CON 1 and CON 2, birds respectively. The rapid response of liver tissue to AL is consistent with previous studies where birds fed AL in combination with inosine Figure 5 . A. IL-12p35 gene expression in broiler liver tissue. ALLO 1 birds (n = 5) were administered 35 mg/kg BW allopurinol in feed for 1 wk. CON 1 (n = 5) were maintained on a commercial diet. Gene expression is represented as the mean ± SEM for each treatment. An asterisk denotes a significant difference as compared to CON 1. Significance is defined as P ≤ 0.05. B. IL-12 p35 gene expression in broiler liver tissue. ALLO 2 birds (n = 5) were administered 35 mg/kg BW allopurinol in feed for 2 wk. CON 2 (n = 5) were maintained on a commercial diet. Gene expression is represented as the mean. Error bars are SEM for each treatment. An asterisk denotes a significant difference as compared to CON 1. Significance is defined as P ≤ 0.05. demonstrated a reduction in liver UA content (Settle et al., 2012) . Interestingly, birds that were fed AL for 2 wk showed that UA remained lower in the liver tissue even after terminating AL treatment which suggests that there was a residual toxic effect on the liver (Settle et al., 2012) .
XOR is the enzyme responsible for the production of UA in the purine degradation pathway. Carro et al. (2009) reported that XOR activity was increased in liver tissue of birds fed AL at a dose of 50 mg/kg/ BW and suggested that this response is a compensatory mechanism to maintain UA levels in this tissue. Furthermore, Settle et al. (2015) concluded that XOR gene expression was upregulated in the liver tissue of broilers administered AL in the diet for 2 wk. In agreement with these findings, XOR gene expression was significantly increased in ALLO 2 birds in a response to the reduced concentrations of UA. It has also been reported that AL can act as both a substrate and an inhibitor of xanthine oxidase which indicates a substrateinduced regulation of XOR in the liver (Massey et al., 1970) . As suggested in previous studies, the increase in xanthine and hypoxanthine concentrations in the liver may be responsible for the increase in XOR activity ALLO 1 birds (n = 5) were administered 35 mg/kg BW allopurinol in feed for 1 wk. CON 1 (n = 5) were maintained on a commercial diet. Gene expression is represented as the mean ±SEM for each treatment. An asterisk denotes a significant difference as compared to CON 1. Significance is defined as P ≤ 0.05. B. The iNOS gene expression in broiler liver tissue. ALLO 2 birds (n = 5) were administered 35 mg/kg BW allopurinol in feed for 2 wk. CON 2 (n = 5) were maintained on a commercial diet. Gene expression is represented as the mean ± SEM for each treatment. An asterisk denotes a significant difference as compared to CON 1. Significance is defined as P ≤ 0.05. (Della-Corte and Stirpe, 1967; Lee and Fisher, 1972; Woodward et al., 1972) . In contrast, there was no difference in XOR gene expression between CON 1 and ALLO 1 birds despite the decrease in UA concentrations in the liver, which suggests that gene expression of XOR is not affected by acute treatment with AL. Clearly, there are many factors regulating gene expression of XOR and so future studies need to address the dose and duration of treatment in order to ascertain the regulatory mechanisms governing this gene.
It has been previously reported that there is a negative relationship between plasma UA concentrations and oxidative stress in broiler chickens such that a decrease in plasma UA is associated with an increase in oxidative stress (Klandorf et al., 2001; Simoyi et al., 2002; Machin et al., 2004; Stinefelt et al., 2005; Seaman et al., 2008; Carro et al., 2009; Settle et al., 2012) . XOR has been shown to participate in antimicrobial defense mechanisms potentially through induction by cytokines, suggesting that this enzyme has a role in immune response (Martelin et al., 2000; Vorbach et al., 2003) . Oxidative stress has been associated with inflammation due to activation of inflammatory cytokines and transcription factors in a plethora Figure 7 . A. XOR gene expression in broiler liver tissue. ALLO 1 birds (n = 5) were administered 35 mg/kg BW allopurinol in feed for 1 wk. CON 1 (n = 5) were maintained on a commercial diet. Gene expression is represented as the mean ± SEM for each treatment. An asterisk denotes a significant difference as compared to CON 1. Significance is defined as P ≤ 0.05. B. XOR gene expression in broiler liver tissue. ALLO 2 birds (n = 5) were administered 35 mg/kg BW allopurinol in feed for 2 wk. CON 2 (n = 5) were maintained on a commercial diet. Gene expression is represented as the mean ± SEM for each treatment. An asterisk denotes a significant difference as compared to CON 1. Significance is defined as P ≤ 0.05. of pathways (Reuter et al., 2010) . In this study, IL-1β was numerically up-regulated in ALLO 1 birds, although this was not significant after one week of treatment with AL. There were no differences observed in expression of IFN-γ, IL-12p35, IL-6, or iNOS in ALLO 1 birds as compared to CON 1. However, after 2 wk treatment with AL, ALLO 2 birds showed a marked increase in gene expression of the pro-inflammatory cytokine IFN-γ as compared to CON 2. Additionally, IL-1β and IL-12p35 gene expression were also up-regulated in ALLO 2 birds. Activation of iNOS by IFN-γ results in the production of nitric oxide which can be directly linked to inflammation (Guzik et al., 2003) . As a numerical increase in iNOS was observed, it is possible that a study of longer duration would reveal an increase iNOS production. As in birds fed AL for 1 wk, there was no change in IL-6 gene expression after 2 wk treatment with AL. IL-6 has been reported to function as both a pro-inflammatory cytokine as well as an anti-inflammatory myokine, remains unchanged in some primary infection responses (Hong et al., 2006) . The increase in expression of the IFN-γ, IL-1β, and IL-12p35 inflammatory cytokines in the liver after 2 wk treatment with AL can be interpreted as an increase in inflammation of this tissue. In previous studies it has been suggested that AL exerts a toxic effect on hawks exhibiting hyperuricemia which was attributed to the increase in oxypurinol, the nephrotoxic end-product of AL (Lumeij and Redig, 1992) . In a second study it was demonstrated that doses ranging from 3 to 100 mg/kg BW are toxic in liver tissue in rats (Suzuki et al., 1984) . Conversely, AL and oxypurinol have been shown to have protective effects in a wide range of inflammatory disease mechanisms of humans and selected animal models (Gibbings et al., 2011) . Although AL has been reported as "safe" for long-term treatment in humans (Rundles, 1985) , the dose used in our study demonstrates a pronounced adverse effect with the results that inflammation being observed the longer the broilers were fed AL. Further, the decrease in protection by UA in this tissue potentially increases the susceptibility of the liver to oxidative damage and inflammation ultimately leading to a decline in health of the bird. The relationship of XOR, AL, and inflammation is very complex and to date has not been fully elucidated. XOR inhibition can alleviate preexisting inflammation or, as our findings suggest, inhibition of XOR in birds can lead to adverse, tissue-specific effects. Based on these data, it can be inferred that a reduction in UA concentrations in the liver can generate a pro-inflammatory response in liver tissue indicating the importance of antioxidant defense by UA.
In conclusion, these studies show that a reduction in UA after 1 wk treatment with AL results in mitochondrial dysfunction in the liver tissue as indicated by the reduction in mitochondrial respiration states. However, the cytosolic UA concentrations in the liver tissue were unchanged after 1 wk in study 1, suggesting that the production rates may have been able to overcome the acute inhibitory effects of AL. Further study is necessary to ascertain this and whether AL has a direct effect on mitochondrial dysfunction or whether the observed changes in mitochondrial function are indirectly due to increased oxidative damage or inflammation. After 2 wk treatment with AL, liver tissue UA is depressed which increases susceptibility to oxidative stress due to the inverse relationship that UA has with oxidative stress. Furthermore, in response to the reduction of UA concentrations in the liver, there is a compensatory up-regulation of XOR gene expression, which is suggested to maintain antioxidant protection by UA. Further studies are required to investigate how XOR is regulated. Based on these previous studies by our laboratory and the focus of this study on mechanisms concerning regulation of UA, oxidative stress was not directly measured in the tissues of this study and will be considered in future studies. The chronic reduction of UA in the liver also results in an increase in the expression of selected inflammatory cytokines which leads to the expression of the inflammatory state. Ultimately, a decrease in UA concentrations has been linked to an increase in oxidative damage. The results presented in these studies provide a foundation for future work in elucidating the exact mechanism by which this occurs, thereby providing insight for understanding the longevity and health of birds.
